Triple Therapy Doubles Survival in Advanced Liver Cancer with Portal Vein Clots
A prospective controlled study in BMC Medicine found that adding hepatic arterial infusion chemotherapy to lenvatinib and a PD-1 inhibitor ...
A prospective controlled study in BMC Medicine found that adding hepatic arterial infusion chemotherapy to lenvatinib and a PD-1 inhibitor ...
Researchers in China have built and validated a statistical survival calculator for young patients with upper tract urothelial carcinoma using ...
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy outperform other immunotherapy combinations ...
A multicenter study of 347 lung cancer patients found that achieving a complication-free, complete surgical course after neoadjuvant therapy independently ...
A retrospective study of 25 patients suggests that adding the anti-PD-1 antibody pucotenlimab to concurrent radiochemotherapy produced tumor responses and ...
The first randomized phase 3 trial comparing postoperative radiation schedules for large brain metastases found that fractionated stereotactic radiosurgery over ...
A retrospective cohort study of 152 glioblastoma patients found that culture-positive infections after radiotherapy, predominantly Gram-negative respiratory and urinary infections, ...
A randomized phase 3 trial found that patients with small cell lung cancer and brain metastases lived a median of ...
A randomized phase III Alliance trial found that delivering postoperative radiosurgery in three to five sessions instead of one significantly ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine